Insider Trading & Ownership of Paradigm Biocapital Advisors LP

Location
New York, NY
Summary
The estimated value of insider holdings of Paradigm Biocapital Advisors LP is at least $173,767,954 dollars as of 05 Aug 2024. Paradigm Biocapital Advisors LP is the 10%+ Owner of Olema Pharmaceuticals, Inc. and owns shares of Olema Pharmaceuticals, Inc. (OLMA) stock worth about $173.77M.
Signature
/s/ David Kim, as an authorized signatory of the Fund and the Adviser GP (for itself and on behalf of the Adviser)
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Paradigm Biocapital Advisors LP and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Paradigm Biocapital Advisors LP has 1 issuer position tracked on this page.
  • Estimated disclosed ownership value: $173,767,954.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Olema Pharmaceuticals, Inc. ($173,767,954).
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Paradigm Biocapital Advisors LP

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
OLMA Olema Pharmaceuticals, Inc. 10%+ Owner $173,767,954 01 Aug 2024

Insider Transactions Reported by Paradigm Biocapital Advisors LP:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored